Duchenne Muscular Dystrophy – An Expanding Lifespan
Jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC
Release date: March 20, 2019
Valid through: March 20, 2020
Specialty: Duchenne Muscular Dystrophy
Estimated Time to Complete Activity: This activity consists of two sessions which should take approximately 2 hours to complete.
This activity is supported by educational grants from Sarepta and PTC Therapeutics.
This activity is intended for pediatricians, neurologists, neuromuscular specialists, endocrinologists, gastroenterologists, pediatric cardiologists, physiatrists, pulmonologists, pediatric neurologists, primary care physicians, advanced practitioners, pharmacists, nurses, and dieticians.
At the conclusion of this activity, participants will be able to:
- Summarize the differential diagnosis of DMD and applicable diagnostic approaches
- Adopt a multidisciplinary approach to diagnosing patients with DMD
- Describe signs and symptoms that would raise a high index of suspicion of DMD
- Identify mutations that may be associated with DMD and how that relates to making treatment decisions
- Assess the therapeutic potential of available and emerging treatment options for the management of DMD
- Adopt a multidisciplinary approach to managing patients with DMD
- Describe elements for a successful transition from childhood to adulthood care in patients with DMD
- Physicians — The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other health care professionals completing this course will be issued a statement of participation.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designtation Statements
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of Participation
There are no fees to participate in this activity. To participate in the activity, go to www.NeuroSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit(s)™, participants must receive a minimum score of 70% on the post-test.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
|Name of Faculty or Presenter||Reported Financial Relationship|
|Richard J. Barohn |
Gertrude and Dewey Ziegler Professor of Neurology
University Distinguished Professor
Vice Chancellor for Research
President of the Research Institute
University of Kansas Medical Center
|Consulting Fees: NuFactor, Momenta Pharma |
Contracted Research: PTC Therapeutics, Ra Pharma, Orphazyme, Sanofi Genzyme, NIH, PCORI
|Oscar H. Mayer, MD |
Professor of Pediatrics
The Perelman School of Medicine at the University of Pennsylvania
Medical Director, Pulmonary Function Testing Laboratory, Division of Pulmonology
The Children’s Hospital of Philadelphia
|Fees for Non-CME/CE Services Received Directly from a Commercial Interest: PTC Therapeutics (educational presentation for employees)|
|Kathryn R. Wagner, MD, PhD |
Professor of Neurology
Johns Hopkins School of Medicine
Director of Center for Genetic Muscle Disorders
The Kennedy Krieger Institute
|Consulting Fees: Lion, Sarepta, PTC, Wave, Fibrogen |
Contracted Research: Pfizer, Sarepta, Catabasis, Roche
|John F. Brandsema, MD |
Assistant Professor Of Clinical Neurology
Perelman School of Medicine
Attending Physician, Neuromuscular/General Neurology & Electromyography, Neuromuscular Education Director and Neuromuscular Section Head
The Children’s Hospital of Philadelphia
|Consulting Fees: Biogen, AveXis, PTC Therapeutics, Sarepta, Alexion, Cytokinetics |
Fees for Non-CME/CE Services Received Directly from a Commercial Interest: Biogen
Contracted Research: Biogen, AveXis, PTC Therapeutics, Sarepta, Alexion, Cytokinetics
|Betty Vertin |
Parent of Children with DMD
|Salary (Spouse): Stellar Industries|
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
|Name of Planner||Reported Financial Relationship|
|David Howard |
PlatformQ Health Education, LLC
The PIM planners and managers have nothing to disclose.
The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Disclosure of Unapproved/Off Label Use (if applicable)
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Course Viewing Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Please contact the Postgraduate Institute for Medicine at www.pimed.com.
For any technical issues or issues with your CME Certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at support@PlatformQHealth.com
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor do we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting firstname.lastname@example.org with the subject line “Data Request”